ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
113.32
+1.86 (1.67%)
At close: Feb 3, 2026, 4:00 PM EST
113.58
+0.26 (0.23%)
After-hours: Feb 3, 2026, 7:53 PM EST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 67 employees as of September 30, 2025. The number of employees increased by 5 or 8.06% compared to the same quarter last year.
Employees
67
Change
5
Growth
8.06%
Revenue / Employee
$93,006
Profits / Employee
-$5,140,086
Market Cap
8.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| BioMarin Pharmaceutical | 3,040 |
| Jazz Pharmaceuticals | 2,800 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 498 |
| Avidity Biosciences | 391 |
| Halozyme Therapeutics | 350 |
ABVX News
- 4 days ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 14 days ago - Abivax CEO dismisses 'noise' around rumored Eli Lilly bid - Reuters
- 22 days ago - Abivax: Don't Just Buy The Rumor, Buy The Fundamentals - Seeking Alpha
- 22 days ago - France has had no request for investment approval in biotech Abivax - official - Reuters
- 22 days ago - Abivax stock rockets 30% on Eli Lilly takeover speculation - Invezz
- 22 days ago - Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid - WSJ
- 22 days ago - Abivax shares soar 23% as media report reignites M&A chatter - Reuters
- 25 days ago - A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year - CNBC